Laboratoires Thea

This study is testing an experimental drug called ultevursen, given as an injection into the eye, for people with a specific genetic type of retinitis pigmentosa (RP). The goal is to see if it can slow down the loss of vision over two years. About 81 participants will be randomly…

This study is testing whether regular eye injections of an experimental drug called sepofarsen can improve vision in people with a specific genetic form of Leber congenital amaurosis (LCA), which causes severe vision loss from childhood. In this carefully designed trial, each par…

This study is testing a new, preservative-free eye drop formula to see if it can relieve the symptoms of dry eye disease and improve patients' quality of life. Thirty adults with dry eye will use the drops daily for six months and report on their symptoms. The main goal is to see…

This study aims to understand how consistently glaucoma patients use their prescribed eye drops in real life. It will follow 200 adult patients in Italy who are already using a specific type of eye drop bottle. Researchers will track their medication use over time using a smart d…